Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI).
Derosa G, Maffioli P, D'Angelo A, Salvadeo SA, Ferrari I, Fogari E, Mereu R, Gravina A, Palumbo I, Randazzo S, Cicero AF. Derosa G, et al. Among authors: gravina a. Endocr J. 2009;56(4):571-8. doi: 10.1507/endocrj.k08e-330. Epub 2009 Apr 7. Endocr J. 2009. PMID: 19352055 Free article. Clinical Trial.
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF. Derosa G, et al. Among authors: gravina a. J Clin Pharm Ther. 2006 Aug;31(4):375-83. doi: 10.1111/j.1365-2710.2006.00756.x. J Clin Pharm Ther. 2006. PMID: 16882108 Clinical Trial.
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin.
Derosa G, Mereu R, D'Angelo A, Salvadeo SA, Ferrari I, Fogari E, Gravina A, Palumbo I, Maffioli P, Randazzo S, Cicero AF. Derosa G, et al. Among authors: gravina a. J Clin Pharm Ther. 2010 Oct;35(5):565-79. doi: 10.1111/j.1365-2710.2009.01132.x. J Clin Pharm Ther. 2010. PMID: 20831680 Clinical Trial.
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD. Derosa G, et al. Among authors: gravina a. Clin Ther. 2006 May;28(5):679-88. doi: 10.1016/j.clinthera.2006.05.012. Clin Ther. 2006. PMID: 16861090 Clinical Trial.
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
Derosa G, Cicero AF, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Fassi R, Fogari R. Derosa G, et al. Among authors: gravina a. Clin Ther. 2007 Apr;29(4):602-10. doi: 10.1016/j.clinthera.2007.03.015. Clin Ther. 2007. PMID: 17617283 Clinical Trial.
276 results